London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
just ticked up
@Ghia : RE the COPD trial, they said this in the 18 March RNS :
"
Synairgen is now close to completing a Phase II study in chronic obstructive pulmonary disease (COPD) patients with confirmed respiratory viral infections and pre-existing significant impairment of lung function. With 109 out of a target 120 participants already dosed, this trial has been paused to minimise the chance of vulnerable patients being exposed to further infection risk and to minimise distraction for respiratory staff in the UK hospitals and GP sites conducting the trial, who will be at the forefront in dealing with patients suffering from COVID-19. We are currently exploring ways to adapt the trial to enable patients in the pre-treatment pool to be dosed if they become infected with SARS-CoV-2.
"
I think most understand it, lots choose to ignore this and post because they think they can influence the price in either direction.
As you say this is not a new drug and was showing promising signs for COPD I believe that trial phase is currently on hold because of the Covid 19 outbreak.
As many have said even if the covid trial fails to prove efficacy we will still have the COPD business to fall back on so there is some support to the share price.
It's also a unique opportunity to further assess the drug in a trial setting i'm sure some data being gathered can be fed back into the COPD and we might be able to accelerate the product through approvals.
@Ghia : Thanks for that information. Best for everyone in the long run if the trial is conducted with discretion.
Ghia, sorry mate you are wrong. SNG have successfully trialled their interferon beta nebuliser on patients suffering from COPD, but not specifically CoVid19. It has a demonstrable proven ability to assist with other types of Coronaviruses.
Why has it not been trialled on CoVid19 before? Because we have not had CoVid19 before. Simples. And that is what so many on this BB do not understand.
well keep your conclusions to your self & stop whittling
I did indeed say leaks next week. About the same time as a certain nurse was tweeting on twitter.
I'm a pharmacist and used to work at Southampton up until last year so I know several people in this trial.
At that point in time my friends where perhaps a bit too loose lipped on what was going on you may have noticed that twitter went very quiet, my friends have now banned me from talking to them about the trial essentially everyone involved got a slap on the wrists and told to tighten up ship.
I doubt we will get anymore leaks until something conclusive is known.
Ghia wake up son on the 6th aprill you were posting leaks from sng next week, now your saying could drift back lol so would a leak next weak denote a drift back ?
I’m not sure why they need to be alone on the positive trial.. if it is a ****tail but an integral ingredient the net effect is the same???
The key is whether it’s Alpha interferon or Beta Interferon.. Synergain only have Beta.. as I understand it... the more informed out here please feel free to correct me...
Correct me if i'm wrong but that document only references injected alpha.
There is a lot out there to suggest interferon will be a useful drug for covid 19.
Until we have trial results there will be nothing that proves the effectiveness of inhaled interferon-beta so all this chat of injected or inhaled alpha although promising for here is a bit of a waste of time in my opinion.
Nice to see a rise here today hopefully it holds but don't be surprised if it drifts back.
Hi Ghia,
Have you seen this Chinese medical extract advising for the use of Interferon in relation to Covid. listed as a KEY treatment. My only concern with the trial is that it seems Interferon was used along side others and that perhaps alone it will not deliver the conclusive results needed.
https://www.fip.org/files/content/priority-areas/coronavirus/CPA-CORONAVIRUS-2019-nCoV-Expert-Consensus-on-Guidance-and-Prevention.pdf
Well fair play. Didn't think this would rise for weeks until RNS. Was hoping for 45p entry. Still hopeful but who knows!
I think most people do get it, but there is only so many times you can post the same articles.
Everyone is hoping for a successful trial so that this drug can start saying lives on the front line.
Easter close will be a blessing so that people don't loose patience and dip out searching for gains elsewhere.
Most on this board don’t get it yet !!
Maybe when the RNS lands about a Global deal it might register.
Some amazing research and post last night. Some real crap today.